Navigation Links
BiovaxID in Medical Technology

Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkin's Lymphoma

WORCESTER, Mass.--(BUSINESS WIRE)--Jun 28, 2007 - Biovest International, Inc. (OTCBB: BVTI), a majority owned subsidiary of Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI), announced on June 27, 2007 blinded interim data from the start of its fast-tracked pivotal Phase 3 clinical trial of BiovaxID(...

Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic Sinusitis

...ovest. Biovest is currently conducting a pivotal Phase 3 clinical trial for biovaxid which is a patient-specific anti-cancer vaccine focusing on the treatment of follicular non-Hodgkin's lymphoma. biovaxid has been granted Fast Track status by the FDA. In addition to these product...
BiovaxID in Biological News

BiovaxID?yields 89 percent survival in patients with aggressive non-Hodgkins

...tional Cancer Institute (NCI) that shows Biovest's biovaxid yielded an 89% survival rate in mantle cell lympho...tients in the study, 23 received vaccinations with biovaxid commencing at least three months after completing ... normal B-cell lymphocytes due to EPOCH-R therapy, biovaxid did induce anti-tumor T-cell lymphocyte responses ...
BiovaxID in other areas

BioVest International - BiovaxID Immunotherapy

BiovaxID Cancer Vaccine Overview ... BiovaxID autologous vaccine is currently undergoing investigation in a phase 3 clinical trial. ...

BioVest International, Inc.

Manufacturer of mammalian cells, as non-GMP or strictly cGMP ... Information on BiovaxID Autologous Immunotherapy and the ASCO Plenary Session (May 31, 2009) ...

Accentia Biopharmaceuticals || Products & Science || BiovaxID

Redefining Immunity for Life ... For scientific publications on BiovaxID, please contact us ... it is anticipated that BiovaxID could potentially be used to ...

Accentia Biopharmaceuticals || Home

Redefining Immunity for Life ... BiovaxID® HealthWatch Video: Anti-Cancer Vaccine Breakthrough ... Idiotype vaccine therapy (BiovaxID) in follicular lymphoma ...

BiovaxID New Drug Application

BiovaxID information from Drugs.com, includes BiovaxID side effects, interactions and indications. ... to File for Accelerated Conditional Approval of BiovaxID ...

BiovaxID: Does It Work? - GLG News

1) BiovaxID shows a 100% improvement in DFS at 3 years (p=0.24) 2) BiovaxID shows an improvement in median overall DFS with a significant P value (p=0.047) 2) ...
Other Tags
(Date:9/18/2014)... 18, 2014 Throughout their lives, sisters ... other on, celebrate their achievements and accomplishments together, and ... and joy. , Joanie’s Sisters in Support, a support ... joined together by their battles against breast and ovarian ... which was organized in June, meets once a month ...
(Date:9/18/2014)... HealthDay Reporter THURSDAY, Sept. 18, 2014 (HealthDay ... therapy effectively treats normally sagging levels of the hormone in ... panel said Wednesday. The panel, from two key FDA ... drugs and require drug makers to conduct tests assessing the ... Bloomberg News . "The whole idea is to try ...
(Date:9/18/2014)... PLAINS, NY, SEPT. 18, 2014 -- Only about half ... shot each season, leaving thousands of moms-to-be and their babies ... a flu shot should be a routine part of prenatal ... officer. "Health care providers should offer their pregnant patients a ... should ask for it." , A report by the U.S. ...
(Date:9/18/2014)... 2014) -- Two independent groups of researchers led ... of Kentucky, and Charles Lowenstein, MD, of the ... the role that a gene called STXBP5 plays ... to Whiteheart, previous genome-wide association studies (GWAS) identified ... regulates a protein called Von Willebrand factor (VWF). ...
(Date:9/18/2014)... is available in German . ... strategy not to fight a pathogen tooth and nail, but rather ... One key feature of tolerance is that the disease only progresses ... carries a high pathogen load. , Roland Regoes, a senior scientist ... approach to HIV. He set about investigating whether there are infected ...
Breaking Medicine News(10 mins):Health News:Artist’s Cancer Jewelry to Benefit Joanie’s Sisters 2Health News:Artist’s Cancer Jewelry to Benefit Joanie’s Sisters 3Health News:FDA Panel: Limit Testosterone Drug Use 2Health News:FDA Panel: Limit Testosterone Drug Use 3Health News:FDA Panel: Limit Testosterone Drug Use 4Health News:Flu vaccine for expectant moms a top priority 2Health News:University of Kentucky research explores STXBP5 gene and its role in blood clotting 2Health News:Withdrawal from the evolutionary race 2Health News:Withdrawal from the evolutionary race 3
(Date:9/17/2014)... in the creation of the Santa Ana Wildfire Threat ... threat potential of the powerful, hot, dry Santa Ana ... The index was introduced Sept. 17 by the U.S. ... Gas and Electric. , The index includes four classification ... used to help fire agencies and other emergency responders, ...
(Date:9/17/2014)... Arlington engineering professor and his doctoral student have designed ... accumulate water collected from fog and dew., The device ... or deserts around the globe., Cheng Luo, professor in ... PhD candidate in the same College of Engineering department, ... edition of ACS, (American Chemical Society) Applied ...
(Date:9/17/2014)... DIEGO, Calif. (Sept. 17, 2014) A rare genetic disorder ... according to a recent joint investigation by researchers at ... San Diego. In addition to suggesting better treatment options ... more clues into the genetic underpinnings of autism., Jacobsen ... the National Institutes of Health. It occurs in a ...
Breaking Biology News(10 mins):UCLA scientists play key role in developing new Santa Ana Wildfire Threat Index 2Shorebird's beak inspires UT Arlington research on water collection 2A link between Jacobsen syndrome and autism 2
Other Contents